In the present study, we found that LPS significantly elevated apoptosis-related gene expression, including PI3K and AKT, as well as Cyto-C, Apaf1, caspase-9, and caspase-3 (Figures 4(a)-4(f)).
(a-f) Sophocarpine decreased the mRNA expression of PI3K, AKT, Cyto-C, Apaf1, caspase-9, and caspase-3 analyzed by real-time PCR; the data are expressed as mean [+ or -] SEM, #P < 0.001.
[4] Human genes:
APAF1, apoptotic peptidase activating factor 1; MAP2K4, mitogen-activated protein kinase kinase 4; TP53, tumor protein p53; DLC1, deleted in liver cancer 1; NMT1, N-myristoyltransferase 1; EF2S1, eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa; DYNLL1, dynein, light chain, LC8-type 1.
It has been demonstrated that interdigital cells and thymocytes obtained from mice lacking the caspase activator
Apaf1 undergo necroptosis instead of apoptosis [43].
Changes of mitochondrial transition pore opening, decreased mitochondrial membrane potential, CL oxidation, and the release of proapoptotic cytochrome c and
Apaf1 molecules are necessary for the execution of the intrinsic mitochondrial apoptotic pathway [140, 141].
This study demonstrated that high doses of AraC, DNR, and MIT did not induce apoptosis-related mRNAs (GADD, SUMO,
Apaf1, Bfl1, BclII, Bim, Bik, Bid, Bad, Bcl-xs, Bak, and Bax) (data not shown).
p53 modulates the expression of Bcl-2 family proteins (e.g., Bax, Bid) and other apoptosis-related gene targets (e.g.,
Apaf1).